Print ISSN:-2249-8176

Online ISSN:-2348-7682

CODEN : PJMSD7

Current Issue

Year 2024

Volume: 14 , Issue: 2

  • Article highlights
  • Article tables
  • Article images

Article Access statistics

Viewed: 199

Emailed: 0

PDF Downloaded: 893


Malik, Khajuria, Khattri, Singh, and Veeresh VG: Prevalence of drug induced thrombocytopenia in five cities of India: A cross sectional descriptive study


Introduction

Drug induced thrombocytopenia is clinical disorder, caused due to administration of therapeutic drugs for management of various diseases.1 More than 300 drugs are identified that can cause drug induced thrombocytopenia,1 the symptoms may begin in 5 to 10 days of drug administration, even with single dose administration can cause immediate effects, 2 the stopping of drugs for 1 to 2 days can recover the patients from complication related to drug effects, the common drugs that lead to drug induced thrombocytopenia are quinidine, 3 vancomycin oxaliiplatin, 4 suramin,5 abciximab, tirofiban, 6 heparin.pencillin, 7 sulfonamide, statins, ranitidine, NSAIDs’. Hence the present study designed to study the prevalence of drug induced thrombocytopenia at various selected cities in North India.

Objectives

The present study is aimed to assess the prevalence of drug induced thrombocytopenia in multiple cities at north India.

Materials and Methods

A survey study designed to assess the prevalence of drug induced thrombocytopenia in multiple cities at north India in Lakhimpur, Panipat, Sonipat, Gohana, Delhi for a period of 11 months from January 2022 to November 2022. A total of 5440 samples from 5 cities were selected from different diagnostic centers, of these at Lakhimpur 1050 samples, Panipat 1465 samples, Sonipat 815 samples, Gohana 845 samples, Delhi 1265 samples respectively were collected with symptoms of decreased platelets count and diseased associated with clinical picture, the blood samples were collected for assessing the thrombocytes count.

Table 1

List of drugsused that caused drug induced thrombocytopenia and number of patients used the respective drugs

S.No.

Drugs induced thrombocytopenia

Number of patients given these drugs

1

Vancomycin

28

2

Linezolid

21

3

Quinolone

19

4

Quinine

17

5

NSIAD’S

15

6

Penicillin

19

7

Sulphonamides

23

8

Chloramphenicol

10

9

Ciclosporin

14

10

Carbamazepine

21

11

Digoxin

13

12

Phenylbutazone

11

13

Phenytoin

15

14

Sodium Valproate

13

15

Tinofiban

10

16

Eptifibatide

7

17

Abciximab

5

Total

261

Results

The present study is designed to assess the prevalence of drug-induced thrombocytopenia. The following are the findings of the study.

Table 2

Describes the distribution of the drug induced thrombocytopenia cases at various cities under study.

S.No.

City

Number of samples

Number of drug induced thrombocytopenia

Percentage

1

Lakhimpur

1050

39

3.7

2

Panipat

1465

66

4.5

3

Sonipat

815

63

7.7

4

Gohana

845

40

4.7

5

Delhi

1265

53

4.1

Total

5440

261

4.7

Table 2, describes the distribution of drug induced thrombocytopenia cases at various selected cities of North India, in Lakhimpur total 1050 samples were collected of them 39 samples, in Panipat total 1465 samples were collected 66 samples, in Sonipat total 815 samples were collected of them 63 samples, in Gohana total 845 samples were collected of them 40 samples and in Delhi total 1265 samples were collected of them 53 samples were drug induced thrombocytopenia respectively.

The study also found that prevalence of drug induced thrombocytopenia in total samples of 5440, at Lakhimpur is 3.7%, Panipat is 4.5%, Sonipat is 7.7%, Gohana is 4.7%, Delhi is 4.1% respectively and total prevalence of drug induced thrombocytopenia in North India is 4.7% is represented in pie diagram.

Table 3

Describes the distribution of gender of the samples having drug induced thrombocytopenia.

S.No.

City

Number of drug induced thrombocytopenia

Male

Percentage

Female

Percentage

1

Lakhimpur

39

20

12.12

19

19.79

2

Panipat

66

40

24.24

26

27.08

3

Sonipat

63

43

26.06

20

20.83

4

Gohana

40

18

10.90

22

22.91

5

Delhi

53

44

26.66

9

9.37

Total

261

165

63.21

96

58.18

FromTable 3, the study found that out of 261 total drug induced thrombocytopenia cases 165 (63.21%) were males and 96 (58.18%) were females. Among which in Lakhimpur out of 39 samples 20 (12.12%) were males and 19 (19.79%) were females, at Panipat in 66 samples 40 (24.24%) were males and 26 (27.08%) were females, at Sonipat 63 samples collected of which 43 (26.06%) were males and 20 (20.83%) were females, at Gohana total 40 samples of them 18 (10.90%) were males and 22 (22.91%) were females and at Delhi 53 samples of them 44 (26.66%) were males and 9 (9.37%) were females respectively, signifies that the prevalence of drug induced thrombocytopenia was high in male than in females.

Table 4

Describes the distribution of the samples according to their age in years.

S.No.

City

Number of drug induced thrombocytopenia

Age in years

Number of samples

Percentage

1

Lakhimpur

39

20 to 40

15

38.46

41 to 60

15

38.46

More than 61

9

23.07

2

Panipat

66

20 to 40

23

34.84

41 to 60

24

36.36

More than 61

19

28.78

3

Sonipat

63

20 to 40

23

36.50

41 to 60

25

39.68

More than 61

15

23.80

4

Gohana

40

20 to 40

10

25.00

41 to 60

15

37.50

More than 61

15

37.50

5

Delhi

53

20 to 40

25

47.16

41 to 60

20

37.73

More than 61

8

15.09

Total

261

261

Table 4, describes the distribution of the samples as per their age in years, in Lakhimpur out of 39 drug induced thrombocytopenia samples 20 to 40 years aged samples were 15(38.46%), 41 to 60 years aged were 15(38.46%) and more than 61 years were 9(23.07%), in Panipat out of 66 drug induced thrombocytopenia samples 20 to 40 years aged samples were 23(34.84%), 41 to 60 years aged were 24 (36.36%) and more than 61 years were 19 (28.78%), in Sonipat out of 63 drug induced thrombocytopenia samples 20 to 40 years aged samples were 23(36.50%), 41 to 60 years aged were 25(39.68%) and more than 61 years were 15 (23.80%), in Gohana out of 40 drug induced thrombocytopenia samples 20 to 40 years aged samples were 10(25.00%), 41 to 60 years aged were 15(37.50%) and more than 61 years were 15(37.50%), in Delhi out of 53 drug induced thrombocytopenia samples 20 to 40 years aged samples were 25(47.16%), 41 to 60 years aged were 20(37.73%) and more than 61 years were 8(15.09%) signifies that the drug induced thrombocytopenia can cause to any age group.

Discussion

The present study aimed to study the prevalence of the drug induced thrombocytopenia cases in selected various cities at North India. The study was conducted at 5 cities are Lakhimpur, Panipat Sonipat, Gohana and Delhi for a period of 11 month from January 2022 to Noveber 2022 collected 5440 samples of which 261 samples were showed drug induced thrombocytopenia.

The present study designed to distribution of the prevalence of the drug induced thrombocytopenia found that the prevalence is 4.7% in selected cities, these findings were similar to the study. 8, 9, 10, 11

the study witnessed that out of 261 samples 165 (63.21%) were males and 96 (58.18%) were females these finding were similar to study 12, 13, 14, 15, 16 and the study also found that the age of drug induced thrombocytopenia is similar in all age groups these findings were similar to the study. 17, 18

Conclusion

Cytotoxic drugs when administered for therapeutic purpose caused drug induced thrombocytopenia, the knowledge of prevalence of disorder prevent the incidence of the disorder and the minimal use of cytotoxic drugs, the present study found that prevalence of drug induced thrombocytopenia as 4.7% which is evident by other studies. This prevalence of drug induced thrombocytopenia in selected cities of North India gives a relevant information to control and prevent the disorder and manage patients as needed.

Source of Funding

None.

Conflict of Interest

None.

References

1 

James N George Richard H Aster Drug-induced thrombocytopenia: pathogenesis, evaluation, and managementHematology Am Soc Hematol Educ Program2009153810.1182/asheducation-2009.1.153

2 

Taman Bakchoul Irene Marini Drug-associated thrombocytopeniaHematology Am Soc Hematol Educ Program20182018157683

3 

S Alegre Herrera M Quirós Valera A Rodríguez Fernández Imipenem/cilastatin-induced acute thrombocytopeniaMed Clin (Barc)200111751978

4 

MS Ali K Berencsi K Marinier N Deltour S Perez-Guthann L Pedersen Comparative cardiovascular safety of strontium ranelate and bisphosphonates: a multi-database study in 5 EU countries by the EU-ADR AllianceOsteoporos. Int2020311224258

5 

DM Arnold S Kukaswadia I Nazi A Esmail L Dewar JW Smith A Systematic Evaluation of Laboratory Testing for Drug-Induced Immune ThrombocytopeniaJ Thromb Haemost201311116976

6 

MU Butt A Jabri SC Elayi Azithromycin-Induced Thrombocytopenia: A Rare Etiology of Drug-Induced Immune ThrombocytopeniaCase Rep Med2019610983110.1155/2019/6109831

7 

E Danese M Montagnana E J Favaloro G Lippi Drug-Induced Thrombocytopenia: Mechanisms and Laboratory DiagnosticsSemin Thromb Hemost202046326474

8 

E Domingo-Chiva M Díaz-Rangel JÁ Monsalve-Naharro P Cuesta-Montero JV Catalá-Ripoll EM García-Martínez Ceftazidime-induced ThrombocytopeniaRev Esp Anestesiol Reanim201764105903

9 

AV Doodnauth S Sivakumar Y Mulatu E Alicea SI Mcfarlane Acute Severe Thrombocytopenia Event Associated with Trimethoprim/Sulfamethoxazole UseAm J Med Case Rep2021931557

10 

N El-Kassar P Kalfon P Fromont C Vezinet B Godeau N Duedari Fusidic Acid Induced Acute Immunologic ThrombocytopeniaBr J Haematol199693242731

11 

SF Garner K Campbell G Smith C Hurd SJ Davidson M Treacy Teicoplanin-dependent antibodies: detection and characterizationBr J Haematol2005129227981

12 

JN George E Raskob SR Shah M A Rizvi SA Hamilton S Osborne Drug-induced Thrombocytopenia: a Systematic Review of Published Case ReportsAnn Intern Med19981291188690

13 

AP Cossu M Musu P Mura LM De Giudici G Finco Linezolid-induced thrombocytopenia in impaired renal function: is it time for a dose adjustment? A case report and review of literatureEur J Clin Pharmacol2014701238

14 

GU Erdem M Dogan NS Demirci N Zengin Oxaliplatin-induced acute thrombocytopeniaJ Cancer Res Ther201612250914

15 

NP Forcello S Khubchandani SJ Patel D Brahaj Oxaliplatin-induced immune-mediated cytopenias: a case report and literature reviewJ Oncol Pharm Pract201521214856

16 

T Mullen L Obeid Ceramide and apoptosis: exploring the enigmatic connections between sphingolipid metabolism and programmed cell death. Anti-Cancer Agents in Medicinal ChemistryAnticancer Agents Med Chem201212434063

17 

ST Towhid A Tolios P Münzer EM Schmidt O Borst M Gawaz Stimulation of platelet apoptosis by balhimycinBiochem Biophys Res Commun201343523236

18 

BR Curtis Drug-induced immune thrombocytopenia: incidence, clinical features, laboratory testing, and pathogenic mechanismsImmunohematology20143025565



jats-html.xsl

© 2024 Published by Innovative Publication Creative Commons Attribution 4.0 International License (creativecommons.org)